Skip to content
Markets News
Stocks1 min read

Vertex Shares Slide 3.07% as Major Indexes Rise

Makkler Newsroom
October 1, 2026

The stock fell despite gains in major indexes, while Zacks consensus estimates point to higher revenue in the upcoming earnings report.

Vertex Pharmaceuticals shares fell 3.07% to $506.74 in the latest session, while the S&P 500 rose 0.2%. The Dow and Nasdaq each gained 0.04%.

The stock lost 6.1% over the previous month, compared with a 1.75% decline for the Medical sector and a 0.35% drop for the S&P 500.

Zacks consensus estimates call for quarterly earnings of $4.86 per share, up 1.25% from the year-earlier quarter, and revenue of $3.4 billion, a 10.43% increase. For the full year, the consensus forecast is $18.85 per share in earnings and $13.21 billion in revenue.

The consensus earnings estimate has fallen 0.95% over the past month, according to Zacks. Vertex trades at a forward price-to-earnings ratio of 27.73, above the industry average of 22.46.

Topics
Further reading

This article was produced with the help of AI technology. Based on reporting by the outlets listed above.

Comments (0)

Log in to join the discussion.Log in

No comments yet - be the first to weigh in.